ARE - CONSENSUS CO - Alexandria

This daily price chart for Alexandria (ARE) reflects a trend supported by the outsourcing of engineering systems and construction, which allows the fund to concentrate on the science sector. Stability is ensured by a life science expert staff with minimal turnover, where the indicator stands at 53.34. The business relies on the ownership of high-cost laboratory complexes in key US technology hubs, guaranteeing high operational resilience.

The stability of Alexandria (ARE) is underpinned by long-term contracts with biopharmaceutical leaders, which is directly reflected in the consensus price target trend. This metric aggregates target values from leading investment houses, measuring the weighted average expected value of the asset while accounting for market liquidity, allowing investors to determine the current gap between the market price and the fundamentally justified fair value.